Obestatin, obesity and diabetes

Peptides

Volumn 30, Issue 2, 2009, Pages 439-444

  Ren, An Jing ^a   Guo, Zhi Fu ^b   Wang, Yang Kai ^a   Lin, Li ^a   Zheng, Xing ^b   Yuan, Wen Jun ^a,c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Ghrelin; Obesity; Obestatin

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; GHRELIN; INSULIN; OBESTATIN; PANCREAS HORMONE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; BODY WEIGHT; CELL SURVIVAL; DIABETES MELLITUS; FOOD INTAKE; HUMAN; IN VIVO STUDY; INSULIN RELEASE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; RODENT; STOMACH EMPTYING; TISSUE DISTRIBUTION;

ANIMALS; DIABETES MELLITUS; EATING; GHRELIN; HUMANS; INSULIN-SECRETING CELLS; OBESITY;

EID: 58149492750     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.10.002     Document Type: Review

References (75)

1. Anderwald-Stadler M., Krebs M., Promintzer M., Mandl M., Bischof M.G., Nowotny P., et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293 (2007) E1393-E1398
2. Ariyasu H., Takaya K., Hosoda H., Iwakura H., Ebihara K., Mori K., et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 143 (2002) 3341-3350
3. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
4. Aydin S., Ozkan Y., Erman F., Gurates B., Kilic N., Colak R., et al. Presence of obestatin in breast milk: relationship among obestatin, ghrelin, and leptin in lactating women. Nutrition 24 (2008) 689-693
5. Bang A.S., Soule S.G., Yandle T.G., Richards A.M., and Pemberton C.J. Characterisation of proghrelin peptides in mammalian tissue and plasma. J Endocrinol 192 (2007) 313-323
6. Bresciani E., Rapetti D., Donà F., Bulgarelli I., Tamiazzo L., Locatelli V., et al. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 29 (2006) RC16-RC18
7. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
8. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89 (2004) 3062-3065
9. Butler M.G., and Bittel D.C. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Genet A 143 (2007) 415-421
10. Camiña J.P., Campos J.F., Caminos J.E., Dieguez C., and Casanueva F.F. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol 211 (2007) 1-9
11. Carlini V.P., Schiöth H.B., and Debarioglio S.R. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 352 (2007) 907-912
12. Catalán V., Gómez-Ambrosi J., Rotellar F., Silva C., Gil M.J., Rodríguez A., et al. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin Endocrinol (Oxf) 66 (2007) 598-601
13. Chanoine J.P., Wong A.C., and Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 66 (2006) 81-88
14. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., et al. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 (2007) 766
15. Chen C., and Lu F.C. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17 Suppl. (2004) 1-36
16. Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H.K., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51 (2002) 124-129
17. De Smet B., Thijs T., Peeters T.L., and Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 19 (2007) 211-217
18. De Spiegeleer B., Vergote V., Pezeshki A., Peremans K., and Burvenich C. Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case. Anal Biochem 376 (2008) 229-234
19. 2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 53 (2004) 3142-3151
20. Donath M.Y., and Halban P.A. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47 (2004) 581-589
21. Dornonville de la Cour C., Björkqvist M., Sandvik A.K., Bakke I., Zhao C.M., Chen D., et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 99 (2001) 141-150
22. Dun S.L., Brailoiu G.C., Brailoiu E., Yang J., Chang J.K., and Dun N.J. Distribution and biological activity of obestatin in the rat. J Endocrinol 191 (2006) 481-489
23. Egido E.M., Herńandez R., Marco J., and Silvestre R.A. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 152 (2009) 61-66
24. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., and Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146 (2002) 241-244
25. Furnes W.M., Stenström B., Tømmerås K., Skoglund T., Dickson S.L., Kulseng B., et al. Feeding behaviour in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res 40 (2008) 279-288
26. Gourcerol G., Coskun T., Craft L.S., Mayer J.P., Heiman M.L., Wang L., et al. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15 (2007) 2643-2652
27. Gourcerol G., Million M., Adelson D.W., Wang Y., Wang L., Rivier J., et al. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 27 (2006) 2811-2819
28. Gourcerol G., St-Pierre D.H., and Taché Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul Pept 141 (2007) 1-7
29. Gourcerol G., and Taché Y. Obestatin - a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil 19 (2007) 161-165
30. Granata R., Settanni F., Gallo D., Trovato L., Biancone L., Cantaluppi V., et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 57 (2008) 967-979
31. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 8 (2007) 981-987
32. Grönberg M., Tsolakis A.V., Magnusson L., Janson E.T., and Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 56 (2008) 793-801
33. Gualillo O., Lago F., Casanueva F.F., and Dieguez C. One ancestor, several peptides post-translational modifications of preproghrelin generate several peptides with antithetical effects. Mol Cell Endocrinol 256 (2006) 1-8
34. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., and Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 92 (2007) 1875-1880
35. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148 (2007) 13-20
36. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
37. Huda M.S., Durham B.H., Wong S.P., Deepak D., Kerrigan D., McCulloch P., et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 32 (2008) 129-135
38. Jackson V.R., Nothacker H.P., and Civelli O. GPR39 receptor expression in the mouse brain. Neuroreport 17 (2006) 813-816
39. Kapica M., Zabielska M., Puzio I., Jankowska A., Kato I., Kuwahara A., et al. Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats - preliminary results. J Physiol Pharmacol 58 Suppl. 3 (2007) 123-130
40. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
41. Lagaud G.J., Young A., Acena A., Morton M.F., Barrett T.D., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 357 (2007) 264-269
42. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351 (2006) 21-25
43. McCowen K.C., Maykel J.A., Bistrian B.R., and Ling P.R. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 175 (2002) R7-11
44. McKee K.K., Tan C.P., Palyha O.C., Liu J., Feighner S.D., Hreniuk D.L., et al. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 46 (1997) 426-434
45. Mészárosová M., Sirotkin A.V., Grossmann R., Darlak K., and Valenzuela F. The effect of obestatin on porcine ovarian granulosa cells. Anim Reprod Sci 108 (2008) 196-207
46. Moechars D., Depoortere I., Moreaux B., de Smet B., Goris I., Hoskens L., et al. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 131 (2006) 1131-1141
47. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
48. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148 (2007) 21-26
49. Pan W., Tu H., and Kastin A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27 (2006) 911-916
50. Park W.H., Oh Y.J., Kim G.Y., Kim S.E., Paik K.H., Han S.J., et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Clin Endocrinol Metab 92 (2007) 229-234
51. Pazos Y., Alvarez C.J., Camiña J.P., and Casanueva F.F. Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 25 (2007) 373-381
52. Prado C.L., Pugh-Bernard A.E., Elghazi L., Sosa-Pineda B., and Sussel L. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci USA 101 (2004) 2924-2929
53. Qader S.S., Håkanson R., Rehfeld J.F., Lundquist I., and Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept 146 (2008) 230-237
54. Qi X., Li L., Yang G., Liu J., Li K., Tang Y., et al. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin Endocrinol (Oxf) 66 (2007) 593-597
55. Reimer M.K., Pacini G., and Ahrén B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144 (2003) 916-921
56. Ren A.J., Guo Z.F., Wang Y.K., Wang L.G., Wang W.Z., Lin L., et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 369 (2008) 969-972
57. Saad M.F., Bernaba B., Hwu C.M., Jinagouda S., Fahmi S., Kogosov E., et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87 (2002) 3997-4000
58. Samson W.K., White M.M., Price C., and Ferguson A.V. Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 292 (2007) R637-R643
59. Seoane L.M., Al-Massadi O., Pazos Y., Pagotto U., and Casanueva F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29 (2006) RC13-RC15
60. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
61. Sibilia V., Bresciani E., Lattuada N., Rapetti D., Locatelli V., De Luca V., et al. Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J Endocrinol Invest 29 (2006) RC31-RC34
62. Szentirmai E., and Krueger J.M. Obestatin alters sleep in rats. Neurosci Lett 404 (2006) 222-226
63. Tremblay F., Perreault M., Klaman L.D., Tobin J.F., Smith E., and Gimeno R.E. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148 (2007) 501-506
64. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
65. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
66. Unniappan S., Speck M., and Kieffer T.J. Metabolic effects of chronic obestatin infusion in rats. Peptides 29 (2008) 1354-1361
67. Vicennati V., Genghini S., De Iasio R., Pasqui F., Pagotto U., and Pasquali R. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol 157 (2007) 295-301
68. Wang L., Saint-Pierre D.H., and Taché Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 325 (2002) 47-51
69. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 (2001) 2540-2547
70. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
71. Zhang J.V., Jahr H., Luo C.W., Klein C., Van Kolen K., Ver Donck L., et al. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol 22 (2008) 1464-1475
72. Zhang J.V., Klein C., Ren P.-G., Kass S., Ver Donck L., Moechars D., et al. Response to comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 (2007) 766
73. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
74. Zhao C.M., Furnes M.W., Stenström B., Kulseng B., and Chen D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 331 (2008) 575-587
75. Zizzari P., Longchamps R., Epelbaum J., and Bluet-Pajot M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148 (2007) 1648-1653